Novel intra‐arterial strategies in the treatment of acute ischaemic stroke

Acute ischaemic stroke is among the leading causes of death and disability in developed societies. I.v. and intra‐arterial thrombolysis, and mechanical thrombectomy carried out within the appropriate time window can result in superior clinical outcomes compared with traditional therapy consisting of anticoagulation and/or aspirin. In cases where thrombolysis and/or thrombectomy have not been proven effective or have failed to result in rapid clinical and/or angiographic improvement, novel intra‐arterial strategies may be applied by experienced interventional neuroradiologists to achieve recanalization of recalcitrant vessel occlusions with good clinical outcomes.

[1]  H. Lutsep,et al.  Mechanical Thrombectomy for Acute Ischemic Stroke: Final Results of the Multi MERCI Trial , 2008, Stroke.

[2]  Adnan I. Qureshi,et al.  Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .

[3]  Wade S. Smith,et al.  Mechanical Thrombectomy of Intracranial Internal Carotid Occlusion: Pooled Results of the MERCI and Multi MERCI Part I Trials , 2007, Stroke.

[4]  W. Smith,et al.  Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. , 2006, AJNR. American journal of neuroradiology.

[5]  G. Donnan,et al.  Quality of stroke care within a hospital: effects of a mobile stroke service , 2005, The Medical journal of Australia.

[6]  R. Higashida,et al.  Intraarterial Thrombolysis Trials in Acute Ischemic Stroke Imaging of Acute Stroke Magnetic Resonance (mr) Imaging , 2022 .

[7]  R. Higashida,et al.  Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .

[8]  J. Grotta,et al.  Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. , 1999, Stroke.

[9]  M. Kaste,et al.  The ECASS 3-Hour Cohort , 1998, Cerebrovascular Diseases.

[10]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[11]  M. Kaste,et al.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.